Delivery Order SPE2DR25D9130-SPE2DR26FCFE9
Award Date 4/2/26
Potential Completion Date 4/23/26
Potential Value $3.9K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 6, 2026, for $11,771.46 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for supply of Nuplazid 34 mg capsules (30-count). PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract with a $499.999 billion ceiling authorizing firm fixed-price delivery orders for pharmaceutical products including branded and generic prescription drugs,...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 6, 2026, for NUPLAZID 34 mg capsule 30s with a ceiling value of $3,923.82. The order was issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract that authorizes firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense military healthcare facilities...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 31, 2026, for NUPLAZID 34 mg capsule 30s with a ceiling value of $3,923.82. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations. Place of...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 2, 2026, for Nuplazid 34 mg capsule supplies, with a ceiling value of $7,847.64, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations worldwide. Place...
- The Defense Logistics Agency issued a $3,923.82 delivery order to DMS Pharmaceutical Group Inc. on March 16, 2026, for NUPLAZID 34 mg capsules under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. Place of performance is Park Ridge, IL. The order carries a firm fixed-price structure with an ultimate completion date of April 6, 2026. This delivery order is issued under the PPV-G GEN...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 24, 2026, for $3,923.82 in firm fixed-price pharmaceutical supply under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract. The order covers Nuplazid 34 mg capsule 30-count units for delivery to Park Ridge, Illinois, with an ultimate completion date of April 14, 2026. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler that holds a...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 8, 2026, for Nuplazid 34 mg capsules with a ceiling value of $3,923.82, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally. DMS...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 13, 2026, for supply of Nuplazid 34 mg capsules, with a ceiling value of $11,771.46. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to military healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical...
- The Defense Logistics Agency issued a $11,771.46 delivery order to DMS Pharmaceutical Group Inc. on February 4, 2026, for Nuplazid 34 mg capsule 30-count units under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under the PPV-G GEN V, a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 13, 2026, for $11,771.46 to supply Nuplazid 34 mg capsules under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is issued under the PPV-G GEN V, a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables...